In a fast-evolving secondaries market now exceeding $150 billion in annual volume, GP-led transactions have emerged as a powerful liquidity tool, reshaping the private equity landscape. We sat down with Petr Poldauf, Senior Investment Director at Schroders Capital, to explore how their focused strategy on GP-led deals offers a compelling answer to the growing demand for flexible exit options, even in emerging regions like Central and Eastern Europe. From venture secondaries to ESG data diligence, Petr shares how Schroders is positioning itself at the forefront of this dynamic segment.
As private equity adapts to a prolonged high-cost environment, investors are being forced to rethink how they source deals, create value, and deploy capital. Ahead of her appearance at 0100 Europe (April 21–23), we spoke with Geraldine O’Keeffe, Partner at EQT Healthcare Growth, about how one of Europe’s leading investment platforms is transiting today’s market dynamics—across healthcare, technology, and beyond.
